Physician

Sucharitha Shanmugam, M.D.

According to 2025 Medicare claims, Sucharitha Shanmugam, M.D. (NPI: 1295941425) practices rheumatology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Chester, PA. This provider's primary affiliated billing organization is RHEUMATOLOGY AND ARTHRITIS CARE CENTER PLLC (NPI: 1245098664; TIN: 842918084) and primary practice location at 19341-2547.

Shanmugam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 870 traditional Medicare patients, billed 293,444 HCPCS/CPT codes, and received $2,740,997 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,220 prescription claims across 382 beneficiaries totaling $827,010 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 107 records totaling $5,089. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $265,544 to $2,740,997. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	397	11,707	$265,544
2016	467	14,138	$380,850
2017	558	29,323	$914,844
2018	488	39,705	$1,126,629
2019	441	43,612	$1,145,296
2020	390	30,146	$721,932
2021	480	117,735	$1,470,936
2022	568	207,855	$1,908,069
2023	562	246,928	$2,135,099
2024	870	293,444	$2,740,997

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	252	1,572	$904,684
2016	313	1,858	$964,054
2017	355	2,172	$1,170,761
2018	331	2,150	$1,357,725
2019	305	1,913	$1,081,154
2020	312	1,301	$617,101
2021	324	1,701	$564,817
2022	371	1,425	$679,291
2023	391	1,355	$786,133
2024	382	1,220	$827,010

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	409	409	$130
96413	Administration of chemotherapy into vein, 1 hour or less	99	547	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	408	707	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	166	184	$68
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	504	726	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	42	1,234	$318,770
Humira(Cf) Pen	Adalimumab	12	336	$77,663
Tymlos	Abaloparatide	16	480	$40,426
Prolia	Denosumab	23	3,870	$38,954
Methotrexate	Methotrexate Sodium	204	15,678	$5,450

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	107	$5,089	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sucharitha Shanmugam, M.D.?

Tedicare shows public-source Medicare data for Sucharitha Shanmugam, M.D. (NPI 1295941425), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sucharitha Shanmugam, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sucharitha Shanmugam, M.D.?

Sucharitha Shanmugam, M.D. is linked to RHEUMATOLOGY AND ARTHRITIS CARE CENTER PLLC (billing NPI 1245098664) in the available physician profile data.

Does Sucharitha Shanmugam, M.D. have Open Payments data?

Sucharitha Shanmugam, M.D. has 107 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.